Drugs / Procysteine
Procysteine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00002114 | ? → Jan 1994 | HIV infectious disease | Free Radical Sciences | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Procysteine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00002114 ↗ |
| Known as | Koprosteine | ChEMBL registry synonym — accepted as the source's own label CHEMBL442218 ↗ |
| Known as | L-2-oxo-4-thiazolidinecarboxylic acid | ChEMBL registry synonym — accepted as the source's own label CHEMBL442218 ↗ |
| Known as | L-2-oxothiazolidine-4-carboxylic acid | ChEMBL registry synonym — accepted as the source's own label CHEMBL442218 ↗ |
| Known as | Oxothiazolidinecarboxylic acid | ChEMBL registry synonym — accepted as the source's own label CHEMBL442218 ↗ |
| Modality | Small molecule | — CHEMBL442218 ↗ |
| Route | Oral | “orally administered Procysteine” NCT00002114 ↗ |